Comprehensive Stock Analysis Of BioMarin Pharmaceutical Inc. (BMRN)

0
39

BioMarin Pharmaceutical Inc. (BMRN) will report its next earnings on Aug 01 AMC. The company reported the earnings of $-0.25/Share in the last quarter where the estimated EPS by analysts was $-0.17/share. The difference between the expected and actual EPS was $-0.08/share, which represents an Earnings surprise of -47.1%.

Many analysts are providing their Estimated Earnings analysis for BioMarin Pharmaceutical Inc. and for the current quarter 16 analysts have projected that the stock could give an Average Earnings estimate of $-0.22/share. These analysts have also projected a Low Estimate of $-0.37/share and a High Estimate of $-0.05/share.

In case of Revenue Estimates, 17 analysts have provided their consensus Average Revenue Estimates for BioMarin Pharmaceutical Inc. as 357.48 Million. According to these analysts, the Low Revenue Estimate for BioMarin Pharmaceutical Inc. is 330 Million and the High Revenue Estimate is 386.6 Million. The company had Year Ago Sales of 317.45 Million.

Some buy side analysts are also providing their Analysis on BioMarin Pharmaceutical Inc., where 4 analysts have rated the stock as Strong buy, 1 analysts have given a Buy signal, 2 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for BioMarin Pharmaceutical Inc. might touch $150 high while the Average Price Target and Low price Target is $114.32 and $92 respectively.

The Relative Volume of the company is 1.31 and Average Volume (3 months) is 1.36 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 590.34.

The company shows its Return on Assets (ROA) value of -3.3%. The Return on Equity (ROE) value stands at -5.2%. While it’s Return on Investment (ROI) value is -1.3%.

While looking at the Stock’s Performance, BioMarin Pharmaceutical Inc. currently shows a Weekly Performance of 8.18%, where Monthly Performance is 14.79%, Quarterly performance is 23.15%, 6 Months performance is 16.91% and yearly performance percentage is 15.34%. Year to Date performance value (YTD perf) value is 15.86%. The Stock currently has a Weekly Volatility of 3.03% and Monthly Volatility of 3.07%.

SHARE